Medical specialty-related adherence to anti-osteoporotic regimens in fragility hip fracture patients

被引:0
|
作者
Chung-Yuan Hsu
Wen-Chan Chiu
Jia-Feng Chen
Ching-Lan Chou
Yu-Jih Su
Shan-Fu Yu
Tien-Tsai Cheng
机构
[1] Kaohsiung Chang Gung Memorial Hospital,Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine
[2] Chang Gung University College of Medicine,undefined
来源
关键词
Hip fracture; Adherence; Specialty;
D O I
暂无
中图分类号
学科分类号
摘要
There is poor adherence in the management of osteoporotic fractures. We designed a study to investigate adherence to osteoporotic regimens among osteoporotic hip fracture patients and to analyze the risk factors associated with poor compliance. This retrospective chart-review study was carried out using a database of osteoporotic hip fracture patients at a medical center in Taiwan for the period 2001–2007. Adherence was assessed using compliance and persistence. Compliance was calculated by the medication possession ratio (MPR) and persistence by the time from treatment initiation to discontinuation. The MPR and corresponding risk factors for poor compliance (MPR < 80 %) were evaluated for year 1. The year 2 results were analyzed only for those subjects with good compliance (MPR ≥ 80 %) at the end of year 1. There were 366 osteoporotic hip fracture patients (323 women, 43 men) with a mean age of 73.9 ± 7.6 years. Of these, 53.8 % had good compliance for year 1 and 68.5 % for year 2. During 2 years of follow-up, the overall persistence ratio was 33.1 %. The risk factor associated with poor compliance in the first year was index prescription by orthopedists [odds ratio (OR) 1.69, 95 % confidence interval (CI) 1.10–2.59]. Subjects with hypertension (OR 0.69, 95 % CI 0.46–0.99) had good compliance. Index prescription by orthopedists (OR 2.44, 95 % CI 1.31–4.51) was the sole risk factor for poor compliance in year 2. In conclusion, although adherence to osteoporotic regimens was sub-optimal in hip fracture patients, the majority of patients’ decreased adherence occurred within the first year. Medical specialties showed different adherences in both year 1 and year 2.
引用
收藏
页码:577 / 583
页数:6
相关论文
共 50 条
  • [31] Strontium ranelate: The first anti-osteoporotic agent to reduce the risk of vertebral fracture in patients with lumbar osteopenia
    Seeman, E
    DeVogelaer, JP
    Lorenc, RS
    Spector, R
    Brixen, K
    Vellas, B
    Balogh, A
    Stucki, G
    Meunier, PJ
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 (06) : 507 - 508
  • [32] Can't Catch a Break: Try Using Anti-Osteoporotic Therapy Commentary on an article by Harpreet S-Bawa, MD, et al.: "Anti-Osteoporotic Therapy After Fragility Fracture Lowers Rate of Subsequent Fracture: Analysis of a Large Population Sample"
    Ong, Kevin L.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2015, 97A (19):
  • [33] FACTORS RELATED TO EARLY COMPLICATION AND PROLONGED HOSPITALISATION OF OSTEOPOROTIC HIP FRACTURE PATIENTS
    Nagavajara, P.
    Chalongviriyalert, P.
    Kittisupakorn, S.
    Wettayavetin, S.
    Tantisevi, K.
    Vittangkul, A.
    Siripaiboonkij, M.
    Ussavarojpong, S.
    Tantikul, C.
    Kerd-Aroonsuksree, T.
    Worawuthangkul, K.
    Phupipatpap, C.
    Charoensopa, T.
    Sirivattanaket, P.
    Sripramote, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S453 - S453
  • [34] Post-Fracture Prescribed Calcium and Vitamin D Supplements Alone or, in Females, with Concomitant Anti-Osteoporotic Drugs is Associated with Lower Mortality in Elderly Hip Fracture Patients A Prospective Analysis
    Nurmi-Luthje, Ilona
    Luthje, Peter
    Kaukonen, Juha-Pekka
    Kataja, Matti
    Kuurne, Salla
    Naboulsi, Helena
    Karjalainen, Kalevi
    DRUGS & AGING, 2009, 26 (05) : 409 - 421
  • [35] Adherence to and appropriateness of anti-osteoporotic treatments in patients aged 50 and over in the Valencia Region (Spain). The ESOSVAL-AD Study
    Sanfelix-Gimeno, Gabriel
    Sanfelix-Genoves, Jose
    Peiro, Salvador
    Hurtado, Isabel
    Luis Trillo, Jose
    Uso, Ruth
    Giner Ruiz, Vicente
    Pascual de la Torre, Manuel
    Ferreros, Inmaculada
    BMC MUSCULOSKELETAL DISORDERS, 2011, 12
  • [36] Adherence to and appropriateness of anti-osteoporotic treatments in patients aged 50 and over in the Valencia Region (Spain). The ESOSVAL-AD Study
    Gabriel Sanfélix-Gimeno
    José Sanfélix-Genovés
    Salvador Peiró
    Isabel Hurtado
    José Luis Trillo
    Ruth Usó
    Vicente Giner Ruiz
    Manuel Pascual de la Torre
    Inmaculada Ferreros
    BMC Musculoskeletal Disorders, 12
  • [37] Association of orthogeriatric co-management with prescription frequencies of anti-osteoporotic drugs in patients with fragility fractures: An observational study with health insurance data
    Rapp, Kilian
    Schoene, Daniel
    Roigk, Patrick
    Becker, Clemens
    Jaensch, Andrea
    Rothenbacher, Dietrich
    Konnopka, Claudia
    Koenig, Hans-Helmut
    Gosch, Markus
    Friess, Thomas
    Buechele, Gisela
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2024, 55 (12):
  • [38] Do patients with osteoporotic hip fracture recover their initial health-related quality of life?
    Ethgen, O
    Tancredi, A
    Jacques, J
    Bruyère, OV
    Richy, F
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S50 - S50
  • [39] Do patients with osteoporotic hip fracture recover their initial health-related quality of life?
    Ethgen, O
    Tancredi, A
    Jacques, J
    Bruyère, O
    Richy, F
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S66 - S66
  • [40] TREATMENT GAP AND MEDICAL COSTS IN PATIENTS WITH AN OSTEOPOROTIC (OP) HIP FRACTURE IN ITALY: A RETROSPECTIVE DATABASE ANALYSIS
    Sciattella, P.
    Scortichini, M.
    Dilecce, M.
    Arcangeli, E.
    Spelta, M.
    Mennini, F. S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S303 - S304